Amphastar Pharma (AMPH) Tops Q1 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Amphastar Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2016
May 9, 2016 4:07 PM EDTRANCHO CUCAMONGA, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (Amphastar or the Company) today reported results for the first quarter ended March 31, 2016.
First Quarter Highlights
Net revenues of $59.4 million for the first quarterGAAP net income of $2.5 million, or $0.05 per diluted share, for the first quarterAdjusted non-GAAP net income of $5.5 million, or $0.12 per diluted share, for the first quarterDr. Jack Zhang, Amphastars CEO, commented:Â We are pleased to announce that we filed... More
